DC Chemicals

All products / DC23173

YHO-13351
CAT. NO. DC23173

YHO-13351

Pack sizes and prices

Pack sizePrice
100 mg$500 USDRequest a quote / confirm availability →
250 mg$1,000 USDRequest a quote / confirm availability →
1 g$2,000 USDRequest a quote / confirm availability →

Confirm stock, lead time, shipping and final quotation with our team.

Product overview

YHO-13351 is an orally available prodrug of YHO-13177, which can specifically reverse BCRP/ABCG2-mediated drug resistance in vitro and in vivo; YHO-13351 is rapidly converted into YHO-13177 after its oral or intravenous administration, significantly increases the survival time of mice inoculated with BCRP-transduced murine leukemia P388 cells and suppressed the tumor growth in an HCT116/BCRP xenograft model coadministration of irinotecan.

For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.

Identity and specifications

Catalog numberDC23173
Product nameYHO-13351
CAS1346753-00-1
Molecular formulaC27H37N3O7S2
Molecular weight579.7286
Purity>98%
SMILESCCN(CC)CC(=O)OC1CCN(c2ccc(C=C(C#N)c3ccc(OC)c(OC)c3)s2)CC1.CS(=O)(=O)O

Source-listed specifications; the batch COA applies.

Source and product documents

The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.

DC Chemicals — YHO-13351 (DC23173)

Related research products

Browse newly added products